Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02124720
Other study ID # CERFAS-2014-15-030-P
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 2014
Est. completion date February 2019

Study information

Verified date September 2019
Source Université de Montréal
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nearly all children with autism spectrum disorders engage in non-functional repetitive vocal and motor behaviours commonly referred to as stereotypy. These repetitive behaviours may considerably interfere with the child's daily functioning, learning, and social inclusion. As such, stereotypy generally has a negative impact on the child and family's health and quality of life. Several behavioural interventions have been developed to reduce engagement in stereotypy in children with autism spectrum disorders, but the limited number of specialists available, the long waiting lists associated with public health services in Canada, and the high costs of private services have considerably restricted accessibility. One potential solution to the limited availability and high costs of services is using a mobile application to recommend, teach, and monitor interventions designed to reduce engagement in stereotypy. To this end, the purpose of the study is to evaluate the effects of the iSTIM (i.e., individualized Stereotypy Treatment Integrated Modules), a mobile application designed to assist parents in reducing stereotypy in children with autism spectrum disorders. Specifically, we will assess whether the iSTIM correctly estimates the frequency or duration of stereotypy, offers suggestions consistent with recommended clinical practices, effectively reduces engagement in stereotypy, and is socially acceptable, safe, and easy to use for parents of children with autism spectrum disorders. The results of the study will allow us to determine whether the mobile application may be used to treat this core symptom in children with autism spectrum disorders, which could potentially reduce waiting times and costs of providing health services to this population. By reducing engagement in stereotypy, the iSTIM may also promote and facilitate the social participation as well as improve the quality of life and health of children with autism spectrum disorders and their families.


Recruitment information / eligibility

Status Completed
Enrollment 39
Est. completion date February 2019
Est. primary completion date February 2019
Accepts healthy volunteers No
Gender All
Age group N/A to 12 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of autism spectrum disorders

- Must engage in at least one form of stereotypy

Exclusion Criteria:

- Stereotypy occurs less than 12 times per hour (or less than 20% of time)

- The form of stereotypy is potentially dangerous for the person (e.g., head banging, self-biting)

- The form of stereotypy is maintained by social consequences (e.g., attention, task avoidance)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
iSTIM
Trained research assistants and parents will implement the assessments and interventions recommended by the iSTIM mobile application during sessions lasting between 10 and 60 minutes

Locations

Country Name City State
Canada Monarch House Mississauga Ontario
Canada CRDITED de Montréal Montreal Quebec
Canada Gold Centre Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Université de Montréal

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Frequency and duration of stereotypy Direct observation of the frequency and duration of stereotypy during 10- to 60-minute sessions 2 to 4 times per week over 8 to 16 weeks
Secondary Social validity score The user responds to a social validity questionnaire Immediately following the end of the intervention (i.e., after 8 to 16 weeks)
See also
  Status Clinical Trial Phase
Recruiting NCT03222375 - SQUEDâ„¢ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism N/A
Completed NCT01233414 - Randomized Trial of Parent Training for Young Children With Autism N/A
Completed NCT00926471 - Social Skills and Anxiety Reduction Treatment for Children and Adolescents With Autism Spectrum Disorders Phase 1
Withdrawn NCT00376194 - Mercury Chelation to Treat Autism Phase 2
Completed NCT02153203 - Using the Prevent-Teach-Reinforce Model to Reduce Problem Behaviors in Children With Autism Spectrum Disorders N/A
Completed NCT02301195 - Trial of Therapeutic Horseback Riding in Children and Adolescents With Autism Spectrum Disorder N/A
Completed NCT00453180 - A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders Phase 2
Completed NCT04475848 - A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants Phase 1
Terminated NCT01517126 - Assessing Suicide Risk in Adolescents With Developmental Delays
Completed NCT00080145 - RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders N/A
Completed NCT00166595 - Pharmacogenetics of Risperidone in Children With Pervasive Developmental Disorder (PDD) Phase 1/Phase 2
Completed NCT01731119 - Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents Phase 2
Completed NCT00147394 - Risperidone Pharmacokinetics in Children With Pervasive Developmental Disorder (PDD) Phase 1
Completed NCT01921244 - Shared Decision Making to Improve Care and Outcomes for Children With Autism N/A
Completed NCT05688319 - Effect of Problem-Solving Training N/A
Terminated NCT00445471 - A Prospective Study Comparing the Mifne Approach of Treating Childhood Autism With Routine Standard Treatment N/A
Active, not recruiting NCT00110708 - Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism Phase 2